The report on the global smoking cessation and nicotine de-addiction products market provides qualitative and quantitative analysis for the period from 2022 to 2028. The report predicts the global smoking cessation and nicotine de-addiction products market to grow with a CAGR of about 15% over the forecast period from 2022-2028. The study on smoking cessation and nicotine de-addiction products market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2022 to 2028.
The report on smoking cessation and nicotine de-addiction products market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global smoking cessation and nicotine de-addiction products market over the period of 2022 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global smoking cessation and nicotine de-addiction products market over the period of 2022 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
The global smoking cessation and nicotine de-addiction products market is segmented on the basis of type, and distribution channel.
The companies covered in the report include
2. Complete coverage of all the segments in the smoking cessation and nicotine de-addiction products market to analyze the trends, developments in the global market and forecast of market size up to 2028.
3. Comprehensive analysis of the companies operating in the global smoking cessation and nicotine de-addiction products market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
The report on smoking cessation and nicotine de-addiction products market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global smoking cessation and nicotine de-addiction products market over the period of 2022 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global smoking cessation and nicotine de-addiction products market over the period of 2022 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings
1) Drivers
- Growing health consciousness among cigarette smokers
- Accessibility to a large range of nicotine replacement therapy (NRT) products
2) Restraints
- High cost associated with smoking cessation products
3) Opportunities
- New product innovations
Research Methodology
A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry
The primary research respondents typically include:
1. Executives working with leading companies in the market under review2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include:
1. Company reports and publications2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
Segment Covered
The global smoking cessation and nicotine de-addiction products market is segmented on the basis of type, and distribution channel.
The Global Smoking Cessation and Nicotine De-addiction Products Market by Type
- E-cigarettes
- Drug Therapy
- Nicotine Replacement Therapies
The Global Smoking Cessation and Nicotine De-addiction Products Market by Distribution Channel
- Drug Store
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Company Profiles
The companies covered in the report include
- Takeda Pharmaceutical Co., Ltd.
- Pfizer, Inc.
- NJOY, Inc.
- Imperial Tobacco Company of India Limited.
- Cipla Ltd.
- Revolymer PLC
- Novartis International AG
- McNeil AB
- Glaxo Smith Kline PLC
- Others
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the smoking cessation and nicotine de-addiction products market.2. Complete coverage of all the segments in the smoking cessation and nicotine de-addiction products market to analyze the trends, developments in the global market and forecast of market size up to 2028.
3. Comprehensive analysis of the companies operating in the global smoking cessation and nicotine de-addiction products market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
2. Executive Summary
3. Global Smoking Cessation and Nicotine De-addiction Products Market Overview
5. The Global Smoking Cessation and Nicotine De-addiction Products Market by Type
6. Global Smoking Cessation and Nicotine De-addiction Products Market by Distribution Channel
7. Global Smoking Cessation and Nicotine De-addiction Products Market by Region 2022-2028
8. Company Profiles and Competitive Landscape
Companies Mentioned
- Takeda Pharmaceutical Co., Ltd.
- Pfizer, Inc.
- NJOY, Inc.
- Imperial Tobacco Company of India Limited.
- Cipla Ltd.
- Revolymer PLC
- Novartis International AG
- McNeil AB
- Glaxo Smith Kline PLC